Citadel Advisors’s Motif Bio plc ADRs MTFB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-24,785
Closed -$9K 10170
2019
Q3
$9K Buy
24,785
+1,179
+5% +$735 ﹤0.01% 9050
2019
Q2
$15K Buy
+23,606
New +$41K ﹤0.01% 8989

Citadel Advisors's MTFB Position: Q4 2019 in Review

Citadel Advisors sold out of Motif Bio plc ADRs (MTFB) in Q4 2019, closing a stake of 24,785 shares — an estimated $9K sold.

Citadel Advisors first reported a position in MTFB in Q2 2019 and held it in 2 quarters. The position peaked at $15K in Q2 2019. 0 funds tracked by Wall St. Rank hold MTFB as of Q4 2019.

  • Citadel Advisors reported no remaining Motif Bio plc ADRs position as of Q4 2019 after selling out during the quarter.
  • Citadel Advisors sold 24,785 Motif Bio plc ADRs shares in Q4 2019, an estimated $9K.
  • Citadel Advisors first reported a position in Motif Bio plc ADRs in Q2 2019 and held it in 2 quarters.
  • Citadel Advisors's Motif Bio plc ADRs position peaked at $15K in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Motif Bio plc ADRs as of Q4 2019.

Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.